Reproductive and Sexual Function Disorders

  • James W. Jefferson
  • John R. Marshall
Part of the Critical Issues in Psychiatry book series (CIPS)


Women and clinicians have long been aware of changes in mental and physical states related to the menstrual cycle. These changes, first described by Frank (1931) as premenstrual feelings consisting of “indescribable tension, irritability,” and “a desire to find relief by foolish and ill-considered actions,” came to be called the premenstrual tension syndrome. Since tension is only one of the components occurring during this period, the term “premenstrual syndrome” is currently preferred, since it more completely encompasses somatic and psychological components. A recent review (Steiner and Carroll, 1977) offers “premenstrual dysphoria” as an alternative term.


Menstrual Cycle Oral Contraceptive Erectile Dysfunction Sexual Dysfunction Premenstrual Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adams PW, Rose DP, Folkard J, et al: Effects of vitamin B6 upon depression associated with oral contraception. Lancet 1: 897–900, 1973.Google Scholar
  2. Albertson P: The new arterial bypass that reverses organic impotence. Sexual Med Today 3:8–13, January 29, 1979.Google Scholar
  3. Altschule, MD, Brem J: Periodic psychoses of puberty. Am J Psychiatry 119: 1176–1178, 1963.PubMedGoogle Scholar
  4. Anonymous: Endocrine basis for sexual dysfunction in men. Br Med J 2: 1516–1517, 1978.Google Scholar
  5. Anonymous: Do drugs cause impotence by lowering penile blood flow? Med World News 20:85, February 19, 1979a.Google Scholar
  6. Anonymous: VA study ties zinc deficiency to male infertility. Med World News 20:12, June 11, 1979b.Google Scholar
  7. Antoniou LD, Shalhoub RJ, Sudhakar T, et al: Reversal of uraemic impotence by zinc. Lancet 2: 895–898, 1977.PubMedGoogle Scholar
  8. Astwood EB: Estrogens and progestins, in Goodman L, Gilman A (eds): The Pharmacological Basis of Therapeutics, ed 4. New York, Macmillan, 1970, pp 1550–1557.Google Scholar
  9. Ayd F: Oral contraceptives—psychic effects. Int Drug Ther News 1: 3–4, 1966.Google Scholar
  10. Bakker CB, Dightman CR: Side effects of oral contraceptives. Obstet Gynecol 28: 373–379, 1966.Google Scholar
  11. Barry JM, Hodges CV: Impotence: A diagnostic approach. J Urol 119: 575–578, 1978.PubMedGoogle Scholar
  12. Baumblatt MJ, Winston F: Pyridoxine and the pill. Lancet 1: 832–833, 1970.PubMedGoogle Scholar
  13. Belmaker RH, Murphy DL, Wyatt RJ, et al: Human platelet monoamine oxidase changes during the menstrual cycle. Arch Gen Psychiatry 31: 553–556, 1974.PubMedGoogle Scholar
  14. Benedek T, Rubenstein B: The correlations between ovarian activity and psychodynamic processes: I. The ovulative phase. Psychosom Med 1: 245–270, 1939a.Google Scholar
  15. Benedek, T, Rubenstein B: The correlations between ovarian activity and psychodynamic processes: II. The menstrual phase. Psychosom Med 1: 461–485, 1939b.Google Scholar
  16. Benedek-Jaszmann LJ, Hearn-Sturtevant MD: Premenstrual tension and functional infertility. Lancet 1: 1095–1098, 1976.PubMedGoogle Scholar
  17. Billetiere E, Fluckiger E: Evidence for a luteolytic function intact cyclic rat using 2-BR-alphaergocryptine (B-154). Experiencia (Basel) 27: 464–466, 1971.Google Scholar
  18. Brown-Parlee M: The premenstrual syndrome. Psychol Bull 80: 454–465, 1973.Google Scholar
  19. Bunney WE, Brodie KH, Murphy DL, et al: Studies of alpha-methyl-para-tyrosine, L-dopa and Ltryptophan in depression and mania. Am J Psychiatry 127: 872–881, 1971.PubMedGoogle Scholar
  20. Carroll BJ, Steiner M: The psychobiology of premenstrual dysphoria: The role of prolactin. Psychoneuroendocrinology 3: 171–180, 1978.PubMedGoogle Scholar
  21. Chopp RT, Mendez R: Sexual function and hormonal abnormalities in uremic men on chronic dialysis and after renal transplantation. Fertil Steril 29: 661–666, 1978.PubMedGoogle Scholar
  22. Claiber EL, Kobayashi Y, Groverman DM, et al: Plasma monoamine oxidase activity in regularly menstruating women and in amenorrheic women receiving cyclic treatment with estrogens and a progestin. J Clin Endocrinol Metab 33: 630–637, 1971.Google Scholar
  23. Cooke WR: The differential psychology of the American woman. Am J Obstet Gynecol 49: 457–460, 1945.Google Scholar
  24. Coppen A, Kessel N: Menstruation and personality. Br J Psychiatry 109: 711–721, 1963.PubMedGoogle Scholar
  25. Coppen AJ, Milne HB, Autran DH, et al: Dytide, norethisterone and a placebo in the premenstrual syndrome—a double-blind comparison. Clin Trials J 6: 33–36, 1969.Google Scholar
  26. Cullberg J: Mood changes and menstrual symptoms with different progestagen/estrogen combinations. Acta Psychiatr Scand 236 (suppl): 1–84, 1972.Google Scholar
  27. Dalton K: Menstruation and acute psychiatric illness. Br Med J 1: 148–149, 1959.PubMedGoogle Scholar
  28. Dalton K: Menstruation and crime. Br Med J 2: 1752–1753, 1961.PubMedGoogle Scholar
  29. Dalton K: The Premenstrual Syndrome. Springfield, Charles C Thomas, 1964.Google Scholar
  30. Dalton K: The influence of a mother’s menstruation on her child. Proc R SocMed 59: 1014–1015, 1966.Google Scholar
  31. Dalton K: Prospective study into puerperal depression. Br J Psychiatry 118: 689–692, 1971.PubMedGoogle Scholar
  32. Davis RE, Smith BK: Pyridoxine and depression associated with oral contraception. Lancet 1: 1245, 1973.PubMedGoogle Scholar
  33. Deutsch H: Psychology of Women. London, Research Books, 1944, p 118.Google Scholar
  34. Endo M, Daiguji M, Wytaka A, et al: Periodic psychoses reoccurring in association with menstrual cycle. J Clin Psychiatry 39: 456–461, 465–466, 1978.Google Scholar
  35. Fisher C, Schiavi RC, Edwards A, et al: Evaluation of nocturnal penile tumescence in the differential diagnosis of sexual impotence. Arch Gen Psychiatry 36: 431–437, 1979.PubMedGoogle Scholar
  36. Fleming O, Seager CP: Incidence of depressive symptoms in users of the oral contraceptive. Br J Psychiatry 132: 431–440, 1978.PubMedGoogle Scholar
  37. Frank RT: The hormonal causes of premenstrual tension. Arch Neurol Psychiatry (Chicago) 26: 1053–1055, 1931.Google Scholar
  38. Fries H: Experience with lithium carbonate treatment at a psychiatric department in the period 1964–1967. Acta Psychiatr Scand 207 (suppl): 41–43, 1969.Google Scholar
  39. Gilmore NJ, Robinson DS, Nies A, et al: Monoamine oxidase levels in pregnancy and during the menstrual cycle. J Psychosom Res 15: 215–220, 1971.PubMedGoogle Scholar
  40. Glass JS, Heninger GR, Lansky N, et al: Psychiatric emergency related to the menstrual cycle. Am J Psychiatry 128: 705–711, 1971.PubMedGoogle Scholar
  41. Glick ID: Mood and behavioral changes associated with the use of the oral contraceptive agents: A review of the literature. Psychopharmacologia 10: 363–374, 1967.PubMedGoogle Scholar
  42. Goldzieher JW, Moses LE, Averkine E, et al: Nervousness and depression attributable to oral contraceptives: A double-blind placebo-controlled study. Am J Obstet Gynecol 111: 1013–1020, 1971.PubMedGoogle Scholar
  43. Gonzalez ER: Hyperprolactinemia: Still perplexing but eminently treatable. DAMA 242: 401–409, 1979.Google Scholar
  44. Grant ECG, Pryse-Davies J: Effects of oral contraceptives on depressive mood changes and on endometrial monoamine oxidase and phosphatases. Br Med J 3: 777–780, 1968.PubMedGoogle Scholar
  45. Greene R, Dalton K: The premenstrual syndrome. Br Med J 1: 1007–1008, 1953.Google Scholar
  46. Gregory BAJC: The menstrual cycle and its disorders in psychiatric patients: I. Review of the literature. J Psychosom Res 2: 61–66, 1957.PubMedGoogle Scholar
  47. Hartoma TR, Nahoul K, Netter A: Zinc, plasma androgens and male sterility. Lancet 2: 1125–1126, 1977.PubMedGoogle Scholar
  48. Heggarty AB: Post-puerperal recurrent depression. Br Med J 1: 637–640, 1955.Google Scholar
  49. Herzberg B, Coppen A: Changes in psychological symptoms in women taking oral contraceptives. Br J Psychiatry 116: 161–164, 1970.PubMedGoogle Scholar
  50. Herzberg BN, Draper KC, Johnson AL, et al: Oral contraceptives, depression and libido. Br Med J 3: 495–500, 1971.PubMedGoogle Scholar
  51. Herzberg BN, Johnson AL, Brown S: Depressive symptoms in oral contraceptives. Br Med J 4: 142–145, 1970.PubMedGoogle Scholar
  52. Hood WE, Bond WL: Enovid therapy for premenstrual tension. Obstet Gynecol 14: 239–241, 1959.PubMedGoogle Scholar
  53. Horowitz JD, Goble AJ: Drugs and impaired male sexual function. Drugs 18: 206–207, 1979.PubMedGoogle Scholar
  54. Horrobin DF, Manku MF, Massar B, et al: Prolactin and fluid and electrolyte balance, in Pasteels JL, Robyn C (eds): Human Prolactin. Amsterdam, Excerpta Medica, 1973, pp 152–155.Google Scholar
  55. Jacobs TI, Charles E: Correlation of psychiatric symptomatology in an outpatient population. Am J Psychiatry 126: 1504–1508, 1970.Google Scholar
  56. Janowsky DS, Berens S, Davis JM: Correlations between mood, weight and electrolytes during the menstrual cycle: A renin–angiotensin–aldosterone hypothesis of premenstrual tension. Psychosom Med 35: 143–154, 1973.PubMedGoogle Scholar
  57. Janowsky DS, Gorney R, Kelly B: “The Curse:” Vicissitudes and variations of the female fertility cycle. Psychosomatics 7: 242–247, 1966.PubMedGoogle Scholar
  58. Janowsky DS, Gorney R, Mandell AJ: The menstrual cycle. Psychiatric and ovarian–adrenocortical hormone correlates: Case study and literature review. Arch Gen Psychiatry 17: 459–464, 1967.Google Scholar
  59. Jordheim O: The premenstrual syndrome—clinical trials of treatment with a progesterone combined with a diuretic compared with both a progesterone and with a placebo. Acta Obstet Gynecol Scand 51: 77–80, 1972.Google Scholar
  60. Kane FJ: Psychiatric reactions to oral contraceptives. Am J Obstet Gynecol 102: 1053–1063, 1968.Google Scholar
  61. Kane FJ, Keeler MH: Use of Enovid in post-partum mental disorders. South Med 158: 1089–1092, 1965.Google Scholar
  62. Karacan I, Salis PJ, Williams RL: The role of the sleep laboratory in diagnosis and treatment of impotence, in Williams RL, Karacan I (eds): Sleep Disorders, Diagnosis and Treatment. New York, John Wiley and Sons, 1978a, pp 353–382.Google Scholar
  63. Karacan I, Ware JC, Dervent B, et al: Impotence and blood pressure in the flaccid penis: Relationship to nocturnal penile tumescence. Sleep 1: 125–132, 1978b.PubMedGoogle Scholar
  64. Kashiwagi T, McClure JN, Wetzel RD: Premenstrual affective syndrome and psychiatric disorder. Dis Nery Syst 37: 116–119, 1976.Google Scholar
  65. Kaya N, Moore, Karacan I: Nocturnal penile tumescence and its role in impotence. Psychiatr Ann 9: 426–431, 1979.Google Scholar
  66. Keeler MH, Daly R, Kane FJ: An acute schizophrenic episode following the abrupt withdrawal of Enovid in a patient with previous post-partum psychiatric disorder. Am J Psychiatry 121:1123–1124, 1964.Google Scholar
  67. Kotin J, Wilbert DE, Verburg D, et al: Thioridazine and sexual dysfunction. Am J Psychiatry 113: 82–85, 1976.Google Scholar
  68. Kramer MS: Menstrual epileptoid psychosis in an adolescent girl. Am J Dis Child 131: 316–317, 1977.PubMedGoogle Scholar
  69. Kramp JL: Studies of the premenstrual syndrome in relation to psychiatry. Acta Psychiatr Scand 203 (suppl): 261–267, 1968.Google Scholar
  70. Kutner SJ, Brown WL: Types of oral contraceptives, depression and premenstrual symptoms. J Nery Ment Dis 155: 153–162, 1972a.Google Scholar
  71. Kutner SJ, Brown WL: History of depression as a risk factor for depression with oral contraceptives and discontinuance. J Nery Ment Dis 155: 163–169, 1972b.Google Scholar
  72. Laidlow J: Catamenial epilepsy. Lancet 2: 1235–1237, 1956.Google Scholar
  73. Leeton J: The relation between oral contraception and depression. Aust N Z J Obstet Gynecol 13: 115–118, 1973.Google Scholar
  74. Lewis A, Hoghughi M: An evaluation of depression as a side effect of oral contraceptives. Br J Psychiatry 115: 697–701, 1969.Google Scholar
  75. Logothetics J, Herner R, Morrell F, et al: The role of estrogen in catamenial exacerbation of epilepsy. Neurology 9: 352–360, 1959.Google Scholar
  76. McClure JN, Reich T, Wetzel RD: Premenstrual symptoms as indicator of bi-polar affective disorder. Br J Psychiatry 119: 527–528, 1971.Google Scholar
  77. MacKinnon IL, MacKinnon PC, Thompson A: Lethal hazards of the luteal phase of the menstrual cycle. Br Med J 1: 1015–1017, 1959.PubMedGoogle Scholar
  78. Malek-Ahmadi D, Behrmann PJ: Depressive syndrome induced by oral contraceptives Dis Nery Syst 37: 406–408, 1976.Google Scholar
  79. Mandell A, Mandell M: Suicide in the menstrual cycle. DAMA 200: 792–793, 1967.Google Scholar
  80. Marcotte DB, Kane FG, Obrist P, et al: Psychophysiologic changes accompanying oral contraceptive use. Br J Psychiatry 116: 165–167, 1970.Google Scholar
  81. Massry SG, Goldstein DA, Procci WR, et al: Impotence in patients with uremia: A possible role for parathyroid hormone. Nephron 19: 305–310, 1977.PubMedGoogle Scholar
  82. Mattsson B, von Schoultz B: A comparison between lithium, placebo, and a diuretic in premenstrual tension. Acta Psychiatr Scand 255 (suppl): 75–84, 1974.Google Scholar
  83. Mendelson JH, Mello NK: Biologic concomitants of alcoholism. N Eng J Med 301:912–921, 1979. Moos RH: Psychological aspects of oral contraceptives. Arch Gen Psychiatry 19: 87–94, 1968a.Google Scholar
  84. Moos RH: The development of a menstrual distress questionnaire. Psychosom Med 30: 853–867, 19686.Google Scholar
  85. Moos RH: Assessment of psychological concomitants of oral contraceptives, in Metabolic Effects of Gonadal Hormones and Contraceptive Steroids. New York, Plenum Press, 1969a, pp 676–705.Google Scholar
  86. Moos RH: Typology of menstrual psychosymptoms. Am J Obstet Gynecol 103: 390–402, 1969b.Google Scholar
  87. Morton JH: Premenstrual tension. Am J Obstet Gynecol 60: 343–352, 1950.Google Scholar
  88. Morton JH, Addition H, Haddison RG, et al: Clinical study of premenstrual tension. Am J Obstet Gynecol 65: 1182–1191, 1953.PubMedGoogle Scholar
  89. Murawaski B: Psychologic considerations for the evaluation of long-term use of oral contraceptives. J Reprod Med 3: 151–155, 1969.Google Scholar
  90. Murawaski B, Sapir B, Shulman N, et al: Investigation of mood states in women taking oral contraceptives. Fertil Steril 19: 50–63, 1968.Google Scholar
  91. Murphy RJ: Compliance dilemma: Antihypertensives and sexual dysfunction. Behav Med 12: 10–14, October 1978.Google Scholar
  92. Nilsson A, Almgren PE: Psychiatric symptoms during the post-partum period as related to use of oral contraceptives. Br Med J 2:453–455, 1968.PubMedGoogle Scholar
  93. Novell HA: Psychological factors in premenstrual tension in dysmenorrhea. Clin Obstet Gynecol 8: 222–232, 1965.Google Scholar
  94. Ota Y, Mukai T, Gotoda K: Studies on the relationship between psychotic symptoms and sexual cycle. Folio Psychiatr Neurol Jpn 8:207–217 1954.Google Scholar
  95. Paige KE: The effects of oral contraceptives on affective fluctuations associated with the menstrual cycle. Psychosom Med 33:515–517, 1971.PubMedGoogle Scholar
  96. Piemme TE: Sexuality and illicit drugs. Med Asp Hum Sexuality 10:85–86 1976.Google Scholar
  97. Prasad AS: Metabolism of zinc and its deficiency in human subjects, in Prasad AS (ed): Zinc Metabolism. Springfield, Charles C Thomas 1966 pp 250–303.Google Scholar
  98. Rees L: Psychosomatic aspects of the premenstrual tension syndrome. Br J Psychiatry 99:162–173, 1953.Google Scholar
  99. Renshaw DC: Inflatable penile prosthesis. JAMA 241:2637–2638 1979.Google Scholar
  100. Ribeiro AL: Menstruation and crime. Br Med J 1:640–641 1962.Google Scholar
  101. Rose DP: Oral contraceptives and depression. Lancet 2:321 1969.Google Scholar
  102. Scott FB, Byrd GJ, Karacan I, et al: Erectile impotence treated with an implantable, inflatable prosthesis. JAMA 241:2609–2612 1979.Google Scholar
  103. Segraves RT: Pharmacological agents causing sexual dysfunction. J Sex Marit Ther 3:157–176, 1977.Google Scholar
  104. Shainess N: Psychiatric evaluation of premenstrual tension. NY State JMed 62:3573–3579,1962.Google Scholar
  105. Silbergeld S, Brast N, Nobel EP: The menstrual cycle—a double-blind study of symptoms, mood and behavior and biochemical variables, using Enovid and placebo. Psychosom Med 33: 411–428, 1971.PubMedGoogle Scholar
  106. Simpson GM, Badinger N, Rochlin D: Enovid in the treatment of psychic disturbances associated with menstruation. Dis New Syst 23:589–590 1962.Google Scholar
  107. Simpson GM, Rochlin D, Kline NS: Further studies of Enovid in the treatment of psychiatric patients. Dis New Syst 25:484–488 1964.Google Scholar
  108. Sletten IW, Gershon S: The premenstrual syndrome: A discussion of its pathophysiology and treatment with lithium ion. Compr Psychiatry 7:197–206 1966.Google Scholar
  109. Small MP: Small-Carrion penile prosthesis: A report on 160 cases and review of the literature. J Urol 119: 365–368, 1978.PubMedGoogle Scholar
  110. Smith SL: Mood and the menstrual cycle, in Sacher EJ (ed): Topics in Psychoendocrinology. New York, Grune & Stratton 1975 pp 19–58.Google Scholar
  111. Somerville BW: The influence of progesterone and estradiol upon migraine. J Headache 12: 93–102, 1972.Google Scholar
  112. Sommer B: The effect of menstruation on cognitive and perceptual–motor behavior: A review. Psychosom Med 35:515–534 1973.PubMedGoogle Scholar
  113. Spark RF, White RA, Connolly PB: Impotence is not always psychogenic: Newer insights into hypothalamic–pituitary–gonadal dysfunction. JAMA 243:750–755 1980.Google Scholar
  114. Steiner M, Carroll BJ: The psychobiology of premenstrual dysphoria: Review of theories and treatments. J Psychoneuroendocrinol 2:321–335 1977.Google Scholar
  115. Stokes J, Mendels J: Pyridoxine and premenstrual tension. Lancet 1:1177–1178 1972.PubMedGoogle Scholar
  116. Swanson DW, Burron A, Floren A, et al: The use of norethynodrel in psychotic females. Am J Psychiatry 120:1101–1103 1964.PubMedGoogle Scholar
  117. Swyer GIM: Treatment of the premenstrual syndrome—value of ethisterone, nephinesin and a placebo compared. Br Med J 1:1410–1414 1955.PubMedGoogle Scholar
  118. Takagi H: Periodic psychosis in preadolescence. Psychiatr Neurol Jpn 61:1194–1208, 1959.Google Scholar
  119. Tonks CN, Rack PH, Rose MJ: Attempted suicide in the menstrual cycle. J Psychosom Res 11: 319–323, 1967.Google Scholar
  120. Tupin JP: Lithium use in non-manic depressive condition. Compr Psychiatry 13:209–214 1972.PubMedGoogle Scholar
  121. Varga L, Lutterbeck BM, Pryor JS, et al: Suppression of puerperal lactation with an ergot alkaloid: A double-blind study. Br Med J 2:743–744 1972.PubMedGoogle Scholar
  122. Vinarova E, Uhlir O, Stika L, et al: Side effects of lithium administration. Activ Nery Sup 14: 105–107, 1972.Google Scholar
  123. Wearing MP: The use of norethindrone (2 mg) and mestranol (1 mg) in infertility control. Can Med Assoc J 89: 239–241, 1963.PubMedGoogle Scholar
  124. Weiss HD: The physiology of human penile erection. Ann Intern Med 76: 793–799, 1972.Google Scholar
  125. Wetzel RD, Reich T, McClure JN, et al: Premenstrual affective syndrome and affective disorder. Br J Psychiatry 127: 219–221, 1975.Google Scholar
  126. Whitehead RE: Women pilots. J Aviat Med 5: 47–49, 1934.Google Scholar
  127. Williams EY, Weekes LR: Premenstrual tension associated with psychotic episodes. J Nery Ment Dis 116: 321–329, 1952.Google Scholar
  128. Winston F: Oral contraceptives, pyridoxine and depression. Am J Psychiatry 30:1217–1221, 1973.Google Scholar

Copyright information

© Plenum Publishing Corporation 1981

Authors and Affiliations

  • James W. Jefferson
    • 1
  • John R. Marshall
    • 1
  1. 1.University of Wisconsin Medical SchoolMadisonUSA

Personalised recommendations